Cytoprotective Role of Alpha-1 Antitrypsin in Vascular Endothelial Cell under Hypoxia/Reoxygenation Condition

Journal of Cardiovascular Pharmacology

Volumn 66, Issue 1, 2015, Pages 96-107

  Feng, Yaling ^a   Hu, Lingqing ^a   Xu, Qian ^a   Yuan, Hua ^a   Ba, Linlin ^a   He, Yue ^a   Che, Haisha ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

cellular permeability; hypoxia reoxygenation; in vitro; ischemia reperfusion injury; oxidative stress; 1 antitrypsin

Indexed keywords

ALPHA 1 ANTITRYPSIN; MITOGEN ACTIVATED PROTEIN KINASE P38; OCCLUDIN; PROTEIN ZO1; RAC1 PROTEIN; SUPEROXIDE DISMUTASE;

APOPTOSIS; ARTICLE; BLOOD VESSEL INJURY; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HYPOXIA; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REOXYGENATION; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; CELL CULTURE; CELL HYPOXIA; DRUG EFFECTS; ENDOTHELIUM CELL; HEK293 CELL LINE; PHYSIOLOGY;

ALPHA 1-ANTITRYPSIN; APOPTOSIS; CELL HYPOXIA; CELLS, CULTURED; CYTOPROTECTION; ENDOTHELIAL CELLS; HEK293 CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS;

EID: 84937409939     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0000000000000250     Document Type: Article

References (38)

1. Ferdinandy P, Hausenloy DJ, Heusch G, et al. Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning. Pharmacol Rev. 2014;66:1142-1174.
2. Fleixo-Lima G, Ventura H, Medini M, et al. Mechanistic evidence in Support of alpha1-antitrypsin as a therapeutic approach for type 1 diabetes. J Diabetes Sci Technol. 2014;8:1193-1203.
3. Lum H, Barr DA, Shaffer JR, et al. Reoxygenation of endothelial cells increases permeability by oxidant-dependent mechanisms. Circ Res. 1992;70:991-998.
4. Guttman O, Yossef R, Freixo-Lima G, et al. Alpha 1-antitrypsin modifies general NK cell interactions with dendritic cells and specific interactions with islet beta-cells in favor of protection from autoimmune diabetes. Immunology. 2014;144:530-539.
5. Zhang B, Lu Y, Campbell-Thompson M, et al. Alpha1-antitrypsin protects beta-cells from apoptosis. Diabetes. 2007;56:1316-1323.
6. Kalis M, Kumar R, Janciauskiene S, et al. Alpha 1-antitrypsin enhances insulin secretion and prevents cytokine-mediated apoptosis in pancreatic beta-cells. Islets. 2010;2:185-189.
7. Granell S, Baldini G, Mohammad S, et al. Sequestration of mutated alpha1-antitrypsin into inclusion bodies is a cell-protective mechanism to maintain endoplasmic reticulum function. Mol Biol Cell. 2008;19: 572-586.
8. Moldthan HL, Hirko AC, Thinschmidt JS, et al. Alpha 1-antitrypsin therapy mitigated ischemic stroke damage in rats. J Stroke Cerebrovasc Dis. 2014;23:e355-e363.
9. Gao W, Zhao J, Kim H, et al. Alpha1-antitrypsin inhibits ischemia reperfusion-induced lung injury by reducing inflammatory response and cell death. J Heart Lung Transplant. 2014;33:309-315.
10. Shan L, Li J, Wei M, et al. Disruption of Rac1 signaling reduces ischemia-reperfusion injury in the diabetic heart by inhibiting calpain. Free Radic Biol Med. 2010;49:1804-1814.
11. Talukder MA, Elnakish MT, Yang F, et al. Cardiomyocyte-specific overexpression of an active form of Rac predisposes the heart to increased myocardial stunning and ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2013;304:H294-H302.
12. Subramaniyam D, Glader P, von Wachenfeldt K, et al. C-36 peptide, a degradation product of alpha1-antitrypsin, modulates human monocyte activation through LPS signaling pathways. Int J Biochem Cell Biol. 2006;38:563-575.
13. Umeda K, Ikenouchi J, Katahira-Tayama S, et al. ZO-1 and ZO-2 independently determine where claudins are polymerized in tight-junction strand formation. Cell. 2006;126:741-754.
14. Katsuno T, Umeda K, Matsui T, et al. Deficiency of zonula occludens-1 causes embryonic lethal phenotype associated with defected yolk sac angiogenesis and apoptosis of embryonic cells. Mol Biol Cell. 2008;19: 2465-2475.
15. Yu AS, McCarthy KM, Francis SA, et al. Knockdown of occludin expression leads to diverse phenotypic alterations in epithelial cells. Am J Physiol Cell Physiol. 2005;288:C1231-C1241.
16. Frenzel E, Wrenger S, Immenschuh S, et al. Acute-phase protein alpha1-antitrypsin-a novel regulator of angiopoietin-like protein 4 transcription and secretion. J Immunol. 2014;192:5354-5362.
17. Guan Y, Watson AJ, Marchiando AM, et al. Redistribution of the tight junction protein ZO-1 during physiological shedding of mouse intestinal epithelial cells. Am J Physiol Cell Physiol. 2011;300:C1404-C1414.
18. Nelson DR, Teckman J, Di Bisceglie AM, et al. Diagnosis and management of patients with alpha1-antitrypsin (A1AT) deficiency. Clin Gastroenterol Hepatol. 2012;10:575-580.
19. Blanco I, Lara B, de Serres F. Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema. Orphanet J Rare Dis. 2011;6:14.
20. Stockley RA. Alpha1-antitrypsin review. Clin Chest Med. 2014;35: 39-50.
21. Kalogeris T, Baines CP, Krenz M, et al. Cell biology of ischemia/reperfusion injury. Int Rev Cell Mol Biol. 2012;298:229-317.
22. Li M, Ma RN, Li LH, et al. Astragaloside IV reduces cerebral edema post-ischemia/reperfusion correlating the suppression of MMP-9 and AQP4. Eur J Pharmacol. 2013;715:189-195.
23. Zehendner CM, Librizzi L, Hedrich J, et al. Moderate hypoxia followed by reoxygenation results in blood-brain barrier breakdown via oxidative stress-dependent tight-junction protein disruption. PLoS One. 2013; 8:e82823.
24. Tong N, Zhang Z, Zhang W, et al. Diosmin alleviates retinal edema by protecting the blood-retinal barrier and reducing retinal vascular permeability during ischemia/reperfusion injury. PLoS One. 2013;8:e61794.
25. Goddard LM, Iruela-Arispe ML. Cellular and molecular regulation of vascular permeability. Thromb Haemost. 2013;109:407-415.
26. Rana A, Goyal N, Ahlawat A, et al. Mechanisms involved in attenuated cardio-protective role of ischemic preconditioning in metabolic disorders. Perfusion. 2014;30:94-105.
27. Tanaka K, Tanaka Y, Miyazaki Y, et al. Therapeutic effect of lecithinized superoxide dismutase on pulmonary emphysema. J Pharmacol Exp Ther. 2011;338:810-818.
28. Versteilen AM, Korstjens IJ, Musters RJ, et al. Rho kinase regulates renal blood flow by modulating eNOS activity in ischemia-reperfusion of the rat kidney. Am J Physiol Ren Physiol. 2006;291:F606-F611.
29. Miller MJ. Preconditioning for cardioprotection against ischemia reperfusion injury: the roles of nitric oxide, reactive oxygen species, heat shock proteins, reactive hyperemia and antioxidants-a mini review. Can J Cardiol. 2001;17:1075-1082.
30. Mahfoudh-Boussaid A, Hadj ATK, Zaouali MA, et al. Effects of trimetazidine on the Akt/eNOS signaling pathway and oxidative stress in an in vivo rat model of renal ischemia-reperfusion. Ren Fail. 2014;36:1436-1442.
31. Bhatt LK, Veeranjaneyulu A. Enhancement of matrix metalloproteinase 2 and 9 inhibitory action of minocycline by aspirin: an approach to attenuate outcome of acute myocardial infarction in diabetes. Arch Med Res. 2014;45:203-209.
32. Wu NC, Wang JJ. Curcumin attenuates liver warm ischemia and reperfusion-induced combined restrictive and obstructive lung disease by reducing matrix metalloprotease 9 activity. Transplant Proc. 2014; 46:1135-1138.
33. Hamada T, Duarte S, Tsuchihashi S, et al. Inducible nitric oxide synthase deficiency impairs matrix metalloproteinase-9 activity and disrupts leukocyte migration in hepatic ischemia/reperfusion injury. Am J Pathol. 2009;174:2265-2277.
34. Ohkubo H, Ito Y, Minamino T, et al. VEGFR1-positive macrophages facilitate liver repair and sinusoidal reconstruction after hepatic ischemia/reperfusion injury. PLoS One. 2014;9:e105533.
35. Thirunavukkarasu M, Juhasz B, Zhan L, et al. VEGFR1 (Flt-1) gene knockout leads to the disruption of VEGF-mediated signaling through the nitric oxide/heme oxygenase pathway in ischemic preconditioned myocardium. Free Radic Biol Med. 2007;42:1487-1495.
36. Harada N, Iimuro Y, Nitta T, et al. Inactivation of the small GTPase Rac1 protects the liver from ischemia/reperfusion injury in the rat. Surgery. 2003;134:480-491.
37. Gao G, Wang W, Tadagavadi RK, et al. TRPM2 mediates ischemic kidney injury and oxidant stress through RAC1. J Clin Invest. 2014; 124:4989-5001.
38. Ozaki M, Haga S, Zhang HQ, et al. Inhibition of hypoxia/reoxygenationinduced oxidative stress in HGF-stimulated antiapoptotic signaling: role of PI3-K and Akt kinase upon rac1. Cell Death Differ. 2003;10:508-515.